Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01719679 · ClinicalTrials.gov registry record · NA

School Located Adolescent Vaccination Study

A NA study of School Located Vaccine Program, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
2,000
Enrollment target
2
Study locations

NCT01719679 is a NA study of School Located Vaccine Program that has completed, run by University of Colorado, Denver. The registered enrollment target is 2,000 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01719679, a NA study of School Located Vaccine Program, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
2,000 participants
Enrollment target
2
Study locations

Study Summary

The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertussis (Tdap), human papillomavirus (HPV), and meningococcal conjugate vaccine (MCV4) and all three combined) among eligible students enrolled in schools with a comprehensive school-based immunization program will be significantly higher than that of students enrolled in schools without a school-based immunization program.

Interventions

  • BEHAVIORAL School Located Vaccine (SLV) Program

Study Locations (2)

Colorado

  • University of Colorado Denver - Aurora
  • Kaiser Permanente Colorado - Denver

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2010-08
Est. Completion 2011-10
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01719679

The ClinicalTrials.gov registry entry for NCT01719679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with School Located Vaccine Program appearing as the primary indexed condition, and to 1 intervention - of which School Located Vaccine (SLV) Program is the first listed.

NCT01719679 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01719679 about?

NCT01719679 is a clinical study titled "School Located Adolescent Vaccination Study". The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertuss...

What is the current status of trial NCT01719679?

This trial is currently completed. It is a NA study. The enrollment target is 2,000 participants. The study started on 2010-08. Estimated completion is 2011-10.

What conditions does trial NCT01719679 study?

This clinical trial studies the following conditions: School Located Vaccine Program.

What interventions are being tested in trial NCT01719679?

The interventions under investigation include: School Located Vaccine (SLV) Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01719679?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01719679 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.